BI-474121

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBI-474121
Drug Alias NameBI-474121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionType 2 cyclic nucleotide phosphodiesterases inhibitors
TargetsType 2 cyclic nucleotide phosphodiesterases
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A